G12D Mutated KRAS

Oncology·MeSH: Pancreatic Neoplasms
0 drugs in development·0 companies·2 clinical trials

Deep-dive into G12D Mutated KRAS

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    G12D Mutated KRAS — Drugs in Development & Clinical Trials | BioSniper